Literature DB >> 4056000

Measurement of amikacin in serum by a latex agglutination inhibition test.

R F Khabbaz, H C Standiford, D Bernstein, H C Nipper, B A Tatem, U Smalls, G L Drusano, E Caplan.   

Abstract

Levels of amikacin in serum were determined in 106 serum specimens by a latex agglutination inhibition card test and by radioimmunoassay (RIA). Linear regression analysis demonstrated a high degree of correlation between the two assays (latex = 0.95 (RIA) + 0.69; r = 0.97). Assay of three control sera containing 7.5, 15, and 30 micrograms of amikacin per ml on 7 separate days showed good reproducibility with a coefficient of variation of 0 to 11.7% for the latex assay compared with 7.01 to 22.2% for RIA. Recovery of amikacin in spiked sera varied between 93 and 108% for the latex assay compared with 90 and 100% for RIA. Because the procedure involves a titer, the latex agglutination inhibition card test produces results which are categorized rather than results which are continuous. However, it is a rapid and specific method for determining amikacin levels in clinical specimens and is particularly useful when processing small numbers of specimens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056000      PMCID: PMC268508          DOI: 10.1128/jcm.22.5.699-701.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Improved acetylating radioenzymatic assay of amikacin, tobramycin, and sisomicin in serum.

Authors:  P Stevens; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Amikacin: a rapid and sensitive radioimmunoassay.

Authors:  J E Lewis; J C Nelson; H A Elder
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

3.  Use and interpretation of common statistical tests in method-comparison studies.

Authors:  J O Westgard; M R Hunt
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

4.  Review of 152 patients with bacteremias treated with amikacin.

Authors:  F P Tally; S L Gorbach
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

5.  Controlled comparison of amikacin and gentamicin.

Authors:  C R Smith; K L Baughman; C Q Edwards; J F Rogers; P S Lietman
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

6.  Latex agglutination inhibition card test for gentamicin assay: clinical evaluation and comparison with radioimmunoassay and bioassay.

Authors:  H C Standiford; D Bernstein; H C Nipper; E Caplan; B Tatem; J S Hall; J Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

7.  Rapid, specific microbiological assay for amikacin (BB-K8).

Authors:  P B Marengo; J Wilkins; G D Overturf
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Amikacin assay in serum by high-performance liquid chromatography.

Authors:  S K Maitra; T T Yoshikawa; C M Steyn; L B Guze; M C Schotz
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.